245 related articles for article (PubMed ID: 16156684)
1. Inhibition of Factor Xa : a potential target for the development of new anticoagulants.
Alexander JH; Singh KP
Am J Cardiovasc Drugs; 2005; 5(5):279-90. PubMed ID: 16156684
[TBL] [Abstract][Full Text] [Related]
2. Novel factor Xa inhibitors for prevention and treatment of thromboembolic diseases.
Kubitza D; Haas S
Expert Opin Investig Drugs; 2006 Aug; 15(8):843-55. PubMed ID: 16859389
[TBL] [Abstract][Full Text] [Related]
3. Clinical and experimental experience with factor Xa inhibitors.
Viles-Gonzalez JF; Gaztanaga J; Zafar UM; Fuster V; Badimon JJ
Am J Cardiovasc Drugs; 2004; 4(6):379-84. PubMed ID: 15554723
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation via anti-Factor Xa inhibition.
Wiles N; Hunt BJ
Lupus; 2006; 15(3):167-71. PubMed ID: 16634371
[TBL] [Abstract][Full Text] [Related]
5. [Factor Xa-inhibition in interventional cardiology].
Ahrens I; Peter K; Bode C
Hamostaseologie; 2007 Dec; 27(5):328-32. PubMed ID: 18060241
[TBL] [Abstract][Full Text] [Related]
6. Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolism.
Robinson DM; Wellington K
Am J Cardiovasc Drugs; 2005; 5(5):335-46. PubMed ID: 16156690
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic and hemorrhagic effects of DX-9065a, a direct and selective factor Xa inhibitor: comparison with a direct thrombin inhibitor and antithrombin III-dependent anticoagulants.
Morishima Y; Tanabe K; Terada Y; Hara T; Kunitada S
Thromb Haemost; 1997 Nov; 78(5):1366-71. PubMed ID: 9408021
[TBL] [Abstract][Full Text] [Related]
8. Evolving concepts in the treatment of venous thromboembolism: the role of factor Xa inhibitors.
Nutescu EA; Helgason CM
Pharmacotherapy; 2004 Jul; 24(7 Pt 2):82S-87S. PubMed ID: 15317403
[TBL] [Abstract][Full Text] [Related]
9. Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism.
Bauer KA; Eriksson BI; Lassen MR; Turpie AG
Curr Opin Pulm Med; 2002 Sep; 8(5):398-404. PubMed ID: 12172443
[TBL] [Abstract][Full Text] [Related]
10. Future therapeutic directions for factor Xa inhibition in the prophylaxis and treatment of thrombotic disorders.
Turpie AG
Am J Health Syst Pharm; 2003 Nov; 60(22 Suppl 7):S20-4. PubMed ID: 14650863
[TBL] [Abstract][Full Text] [Related]
11. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
Huisman MV; Bounameaux H
Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
[TBL] [Abstract][Full Text] [Related]
12. Promise of factor Xa inhibition in acute coronary syndromes.
Lee L; Chew D
Curr Cardiol Rep; 2012 Feb; 14(1):40-8. PubMed ID: 22081368
[TBL] [Abstract][Full Text] [Related]
13. New anticoagulants.
Bauer KA
Hematology Am Soc Hematol Educ Program; 2006; ():450-6. PubMed ID: 17124098
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-acting synthetic pentasaccharides.
Koopman MM; Büller HR
J Intern Med; 2003 Oct; 254(4):335-42. PubMed ID: 12974872
[TBL] [Abstract][Full Text] [Related]
15. Management of acute coronary syndromes with fondaparinux.
Wienbergen H; Zeymer U
Vasc Health Risk Manag; 2007; 3(3):321-9. PubMed ID: 17703640
[TBL] [Abstract][Full Text] [Related]
16. The role of ximelagatran in the treatment of venous thromboembolism.
Schulman S
Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():18-24. PubMed ID: 15812200
[TBL] [Abstract][Full Text] [Related]
17. Fondaparinux, the first selective factor Xa inhibitor.
Turpie AG; Eriksson BI; Lassen MR; Bauer KA
Curr Opin Hematol; 2003 Sep; 10(5):327-32. PubMed ID: 12913785
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials with factor Xa inhibition in the prevention of postoperative venous thromboembolism.
Hawkins D
Am J Health Syst Pharm; 2003 Nov; 60(22 Suppl 7):S6-10. PubMed ID: 14650860
[TBL] [Abstract][Full Text] [Related]
19. [Advances in antithrombotic treatment--antithrombotics with anti-Xa effect].
Bátorová A
Vnitr Lek; 2009 Mar; 55(3):295-301. PubMed ID: 19378862
[TBL] [Abstract][Full Text] [Related]
20. Fondaparinux: a synthetic selective factor-Xa inhibitor.
Wong NN
Heart Dis; 2003; 5(4):295-302. PubMed ID: 12877762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
